Lena Biosciences
  • Home
  • Company
    • About us
    • Partners >
      • New Partnerships
    • Careers
    • News >
      • Press Dr. Eckhard von Keutz
    • Events
  • Technology
    • Overview
    • Science >
      • Why 3D?
      • Our 3D models
      • Cell Types
      • Assays
    • Perfused Organ Panel
    • SeedEZ
    • Blood Substitute
    • GradientEZ
    • Publications
    • Featured publication
  • Shop
    • Services >
      • Liver toxicity service
      • Mitochondrial toxicity service
    • Products >
      • Perfused Organ Panel microphysiological system
      • SeedEZ 3D cell culture scaffold
      • GradientEZ 3D cell invasion assay
    • Distributors
  • Support
    • Instructions
    • Cell Types
    • 3D cell-based assays
    • Applications
    • FAQs
    • Contact us

​
​
​

Press releases​

Dr. Eckhard von Keutz joins Lena Biosciences business and science advisory boards
Lena Biosciences appoints Dr. Eckhard von Keutz to its Business Advisory Board and Science Advisory Board
​​

Company in the news​

Lena Biosciences featured in the 3D cell culture market report
Lena Biosciences featured in
​3D Cell Culture Market Report
​​

Announcements and awards​

Lena Biosciences awarded Phase II SBIR from the NIEHS
August, 2024
​

Lena Biosciences is awarded $1.96 M Phase II SBIR
to develop a "virtual human population" screen 
for predictive toxicology
​which incorporates human genetic variability to isolate:
  1. Sensitive individuals; early responders to toxicants
  2. Susceptible individuals who respond adversely to lower doses of toxicants than an "average" human, and
  3. Vulnerable individuals who respond to toxicants through different dose-dependent mechanisms
PLOS ONE publication with PerfusionPal
Landmark study with PerfusionPal featured in PLoS One:
Drug testing in fully humanized, 3D, perfused breast cancer model
Lena Biosciences awarded Phase II SBIR from the NIEHS
Lena Biosciences receives over $1.8 M Phase II SBIR grant award to apply its screening platform to toxicity testing of chemicals implicated in neurodegenerative diseases
Lena Biosciences Mass Challenge Accelerator alumni
2022 Finalist
Mass Challenge US Early Stage Accelerator
Lena Biosciences awarded Phase I SBIR from the National Center for Advancing Translational Sciences
Lena Biosciences receives $300 K  Phase I SBIR grant award to apply its screening platform to drug-induced liver injury
Lena Biosciences finalist in the RESI Longevity Pitch Challenge
Finalist RESI Longevity Pitch Challenge
Therapeutics and Diagnostics, Sept. 2021

Lena Biosciences publishes results with PerfusionPal drug metabolism in the Frontiers of Biomolecular Sciences
Lena Biosciences publishes Phase I drug metabolism results with PerfusionPal 
Lena Biosciences published a study with SeedEZ 3D cell culture scaffold in the Journal of Microelectromechanical Systems
Interdigitated electrodes on SeedEZ scaffolds monitor cardiomyocyte growth
Lena Biosciences awarded a phase I SBIR from the National Institute of Environmental Health Sciences
Lena Biosciences receives $252 K Phase I SBIR grant award to apply its screening platform to toxicity testing of agrochemicals
Lena Biosciences partnered with SpeciCare, a tumor tissue bank
Lena Biosciences and SpeciCare, a tumor tissue bank, announce collaboration
​
​​Learn about 3D cell culture and Perfused Organ Panel technology
ATTEND OUR EDUCATIONAL WEBINARS
REQUEST A SAMPLE
Privacy policy
Copyright © 2024
  • Home
  • Company
    • About us
    • Partners >
      • New Partnerships
    • Careers
    • News >
      • Press Dr. Eckhard von Keutz
    • Events
  • Technology
    • Overview
    • Science >
      • Why 3D?
      • Our 3D models
      • Cell Types
      • Assays
    • Perfused Organ Panel
    • SeedEZ
    • Blood Substitute
    • GradientEZ
    • Publications
    • Featured publication
  • Shop
    • Services >
      • Liver toxicity service
      • Mitochondrial toxicity service
    • Products >
      • Perfused Organ Panel microphysiological system
      • SeedEZ 3D cell culture scaffold
      • GradientEZ 3D cell invasion assay
    • Distributors
  • Support
    • Instructions
    • Cell Types
    • 3D cell-based assays
    • Applications
    • FAQs
    • Contact us